Literature DB >> 24599345

Secondary radiation dose during high-energy total body irradiation.

M Janiszewska1, K Polaczek-Grelik, M Raczkowski, B Szafron, A Konefał, W Zipper.   

Abstract

AIM: The goal of this work was to assess the additional dose from secondary neutrons and γ-rays generated during total body irradiation (TBI) using a medical linac X-ray beam.
BACKGROUND: Nuclear reactions that occur in the accelerator construction during emission of high-energy beams in teleradiotherapy are the source of secondary radiation. Induced activity is dependent on the half-lives of the generated radionuclides, whereas neutron flux accompanies the treatment process only.
MATERIALS AND METHODS: The TBI procedure using a 18 MV beam (Clinac 2100) was considered. Lateral and anterior-posterior/posterior-anterior fractions were investigated during delivery of 2 Gy of therapeutic dose. Neutron and photon flux densities were measured using neutron activation analysis (NAA) and semiconductor spectrometry. The secondary dose was estimated applying the fluence-to-dose conversion coefficients.
RESULTS: The main contribution to the secondary dose is associated with fast neutrons. The main sources of γ-radiation are the following: (56)Mn in the stainless steel and (187)W of the collimation system as well as positron emitters, activated via (n,γ) and (γ,n) processes, respectively. In addition to 12 Gy of therapeutic dose, the patient could receive 57.43 mSv in the studied conditions, including 4.63 μSv from activated radionuclides.
CONCLUSION: Neutron dose is mainly influenced by the time of beam emission. However, it is moderated by long source-surface distances (SSD) and application of plexiglass plates covering the patient body during treatment. Secondary radiation gives the whole body a dose, which should be taken into consideration especially when one fraction of irradiation does not cover the whole body at once.

Entities:  

Mesh:

Year:  2014        PMID: 24599345     DOI: 10.1007/s00066-014-0635-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  20 in total

1.  Dose to radiation therapists from activation at high-energy accelerators used for conventional and intensity-modulated radiation therapy.

Authors:  J Alan Rawlinson; Mohammad K Islam; Duncan M Galbraith
Journal:  Med Phys       Date:  2002-04       Impact factor: 4.071

2.  Characteristics of induced activity from medical linear accelerators.

Authors:  Yi Zhen Wang; Michael D C Evans; Ervin B Podgorsak
Journal:  Med Phys       Date:  2005-09       Impact factor: 4.071

3.  Monte Carlo study of Siemens PRIMUS photoneutron production.

Authors:  J Pena; L Franco; F Gómez; A Iglesias; J Pardo; M Pombar
Journal:  Phys Med Biol       Date:  2005-12-06       Impact factor: 3.609

4.  Photoneutron production of a Siemens Primus linear accelerator studied by Monte Carlo methods and a paired magnesium and boron coated magnesium ionization chamber system.

Authors:  J Becker; E Brunckhorst; R Schmidt
Journal:  Phys Med Biol       Date:  2007-10-11       Impact factor: 3.609

5.  Retrospective, monocentric analysis of late effects after Total Body Irradiation (TBI) in adults.

Authors:  Tobias Bölling; David Christoph Kreuziger; Iris Ernst; Hassan Elsayed; Normann Willich
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

6.  Meningioma as second malignant neoplasm after oncological treatment during childhood.

Authors:  H L Müller; U Gebhardt; M Warmuth-Metz; T Pietsch; N Sörensen; R-D Kortmann
Journal:  Strahlenther Onkol       Date:  2012-03-14       Impact factor: 3.621

7.  In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT.

Authors:  Chester S Reft; Renate Runkel-Muller; Leon Myrianthopoulos
Journal:  Med Phys       Date:  2006-10       Impact factor: 4.071

8.  Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.

Authors:  Myonggeun Yoon; Sung Hwan Ahn; Jinsung Kim; Dong Ho Shin; Sung Yong Park; Se Byeong Lee; Kyung Hwan Shin; Kwan Ho Cho
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-10-30       Impact factor: 7.038

Review 9.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT.

Authors:  Eric J Hall; Cheng-Shie Wuu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-05-01       Impact factor: 7.038

10.  Whole body radiotherapy: A TBI-guideline.

Authors:  Ulrich Quast
Journal:  J Med Phys       Date:  2006-01
View more
  2 in total

1.  MC safe bunker designing for an 18 MV linac with nanoparticles included primary barriers and effect of the nanoparticles on the shielding aspects.

Authors:  Amir Ghasemi-Jangjoo; Hosein Ghiasi
Journal:  Rep Pract Oncol Radiother       Date:  2019-06-06

2.  Monte Carlo study on the secondary cancer risk estimations for patients undergoing prostate radiotherapy: A humanoid phantom study.

Authors:  Amir Ghasemi-Jangjoo; Hosein Ghiasi
Journal:  Rep Pract Oncol Radiother       Date:  2020-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.